Sierra Oncology Inc Shares Near 52-Week High - Market Mover
The shares closed 0.7% below its 52-week high of $54.97, with trading volume lower than its 30 day average
May 13, 2022 by Kwhen Finance Editors
Sierra Oncology Inc (SRRA) shares closed today at 0.7% below its 52 week high of $54.97, giving the company a market cap of $1B. The stock is currently up 151.2% year-to-date, up 210.3% over the past 12 months, and up 9.2% over the past five years. This week, the Dow Jones Industrial Average fell 2.1%, and the S&P 500 fell 2.3%.
Trading Activity
- Trading volume this week was 37.0% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Sierra Oncology Inc | 0.2 | 151.2 | 210.3 | -0.9 | 265.5 |
Dow Jones Industrial Average | 1.4 | -10.9 | -3.7 | -12.9 | 2.5 |
S&P 500 Index | 2.4 | -15.2 | -0.8 | -17.1 | 3.0 |
Health Care | 1.3 | -10.5 | 2.3 | -11.7 | 3.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -1606.8%
- The company's stock price performance over the past 12 months beats the peer average by -1710.2%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Sierra Oncology Inc | SRRA | 0 | 151.2 | 210.3 | -0.9 | 265.5 |
Peer Avg | N/A | 2.2 | -10.0 | -13.1 | -20.2 | 5.2 |
Novartis AG - ADR | NVS | 8.6 | 2.2 | 0.5 | -8.7 | 13.0 |
Ocuphire Pharma Inc | OCUP | 0 | -42.4 | -52.7 | -72.3 | 7.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: